Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1996 2
1997 2
1999 1
2000 1
2001 3
2002 3
2003 2
2004 3
2005 4
2006 2
2007 5
2008 6
2009 15
2010 5
2011 8
2012 11
2013 13
2014 14
2015 8
2016 11
2017 12
2018 17
2019 11
2020 11
2021 10
2022 6
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Results by year

Filters applied: . Clear all
Page 1
Hereditary Paraganglioma-Pheochromocytoma Syndromes.
Else T, Greenberg S, Fishbein L. Else T, et al. 2008 May 21 [updated 2023 Sep 21]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2008 May 21 [updated 2023 Sep 21]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 20301715 Free Books & Documents. Review.
CLINICAL CHARACTERISTICS: Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are characterized by paragangliomas (tumors that arise from neuroendocrine tissues distributed along the paravertebral axis from the base of the skull to the pelvis …
CLINICAL CHARACTERISTICS: Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are characterized by paragan …
Pathological mechanisms and parent-of-origin effects in hereditary paraganglioma/pheochromocytoma (PGL/PCC).
Müller U. Müller U. Neurogenetics. 2011 Aug;12(3):175-81. doi: 10.1007/s10048-011-0280-y. Epub 2011 Mar 9. Neurogenetics. 2011. PMID: 21547462 Review.
Paragangliomas/pheochromocytomas (PGL/PCC) are tumors of the paraganglia. They can occur sporadically, as one sign in a hereditary (tumor) syndrome or as the only manifestation in hereditary PGL/PCC. ...Mutations in the large subunit genes SDHB, …
Paragangliomas/pheochromocytomas (PGL/PCC) are tumors of the paraganglia. They can occur sporadically, as one sign in a her …
Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes.
Turin CG, Crenshaw MM, Fishbein L. Turin CG, et al. Endocr Oncol. 2022 Jun 28;2(1):R65-R77. doi: 10.1530/EO-22-0044. eCollection 2022 Jan. Endocr Oncol. 2022. PMID: 37435466 Free PMC article. Review.
Pheochromocytomas (PCCs) and paragangliomas (PGLs) are neuroendocrine tumors arising from the adrenal medulla and extra-adrenal ganglia, respectively. Approximately 15-25% of PCC/PGL can become metastatic. Up to 30-40% of patients with PCC/PGL have a germline …
Pheochromocytomas (PCCs) and paragangliomas (PGLs) are neuroendocrine tumors arising from the adrenal medulla and extra-adrenal gangl …
Hereditary paragangliomas.
Raygada M, Pasini B, Stratakis CA. Raygada M, et al. Adv Otorhinolaryngol. 2011;70:99-106. doi: 10.1159/000322484. Epub 2011 Feb 24. Adv Otorhinolaryngol. 2011. PMID: 21358191 Free PMC article. Review.
Paragangliomas (PGL) and pheochromocytomas (PCC) are rare, usually benign tumors that originate from the neuroendocrine tissue along the paravertebral axis. ...Less frequently, mutations in the genes responsible for Von Hippel Lindau disease (VHL), multiple endocrin …
Paragangliomas (PGL) and pheochromocytomas (PCC) are rare, usually benign tumors that originate from the neuroendocrine tissue …
Clinical presentation of sporadic and hereditary pheochromocytoma/paraganglioma.
Lider Burciulescu SM, Randon C, Duprez F, Huvenne W, Creytens D, Claes KBM, de Putter R, T'Sjoen G, Badiu C, Lapauw B. Lider Burciulescu SM, et al. Endocr Oncol. 2023 Jan 11;3(1):e220040. doi: 10.1530/EO-22-0040. eCollection 2023 Jan 1. Endocr Oncol. 2023. PMID: 37434651 Free PMC article.
Pheochromocytomas (PHEO) and paragangliomas (PGL) can occur sporadic or within genetic predisposition syndromes. Despite shared embryology, there are important differences between PHEO and PGL. ...In conclusion, we found that patients with PGL more fre …
Pheochromocytomas (PHEO) and paragangliomas (PGL) can occur sporadic or within genetic predisposition syndromes. Despite share …
Hereditary Pheochromocytoma.
Santos P, Pimenta T, Taveira-Gomes A. Santos P, et al. Int J Surg Pathol. 2014 Aug;22(5):393-400. doi: 10.1177/1066896914537683. Epub 2014 Jun 5. Int J Surg Pathol. 2014. PMID: 24903423 Review.
INTRODUCTION: Pheochromocytomas (PHEO) and paragangliomas (PGL) are rare neuroendocrine tumors with an estimated occurrence of 2 to 5 patients per million per year and an incidence of about 1 per 100 000 in the general population. These tumors may arise sporadically …
INTRODUCTION: Pheochromocytomas (PHEO) and paragangliomas (PGL) are rare neuroendocrine tumors with an estimated occurrence of …
Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?
Fishbein L. Fishbein L. Curr Cardiol Rep. 2019 Jul 31;21(9):104. doi: 10.1007/s11886-019-1184-y. Curr Cardiol Rep. 2019. PMID: 31367972 Review.
Pheochromocytomas and paragangliomas (PCC/PGL) are neuroendocrine tumors of the adrenal medulla and extra-adrenal ganglia which often over-secrete catecholamines leading to cardiovascular morbidity and even mortality. ...Patients with sporadic or hereditary P …
Pheochromocytomas and paragangliomas (PCC/PGL) are neuroendocrine tumors of the adrenal medulla and extra-adrenal ganglia whic …
Hereditary pheochromocytoma and paraganglioma.
Mazzaglia PJ. Mazzaglia PJ. J Surg Oncol. 2012 Oct 1;106(5):580-5. doi: 10.1002/jso.23157. Epub 2012 May 30. J Surg Oncol. 2012. PMID: 22648936 Review.
Hereditary pheochromocytomas (pheo) and paragangliomas (pgl) are caused by identifiable germline mutations. ...
Hereditary pheochromocytomas (pheo) and paragangliomas (pgl) are caused by identifiable germline mutations. ...
Pheochromocytoma and paraganglioma.
Pacak K, Wimalawansa SJ. Pacak K, et al. Endocr Pract. 2015 Apr;21(4):406-12. doi: 10.4158/EP14481.RA. Epub 2015 Feb 25. Endocr Pract. 2015. PMID: 25716634 Review.
Most of the susceptibility genes are well characterized and associated with specific clinical presentations, including biochemical phenotype, tumor location and behavior, as well as neoplasms or similar characteristics. Correct and early detection of hereditary PHEO/PGL …
Most of the susceptibility genes are well characterized and associated with specific clinical presentations, including biochemical phenotype …
Succinate dehydrogenase (SDH)-deficient neoplasia.
Gill AJ. Gill AJ. Histopathology. 2018 Jan;72(1):106-116. doi: 10.1111/his.13277. Histopathology. 2018. PMID: 29239034 Review.
Fifteen per cent of pheochromocytoma and paraganglioma (PHEO/PGL) are associated with germline SDH mutation, and therefore SDH-deficient. ...Thirty per cent are associated with SDHA germline mutation and 50% are associated with SDHC epimutation (post-zygotic promote …
Fifteen per cent of pheochromocytoma and paraganglioma (PHEO/PGL) are associated with germline SDH mutation, and therefore SDH …
189 results